Paradigm Spine Receives FDA Approval for Spinal Stenosis Device

Paradigm Spine has won FDA premarket approval for its coflex device, a minimally invasive motion-preserving interlaminar stabilization device for spinal stenosis.

Advertisement

A six-year clinical trial of coflex shows shorter hospital stays, faster procedures and improved pain and function compared to patients who underwent pedicle screw fusions.

More Articles on Orthopedic Devices:

Johnson & Johnson Worldwide Medical Device, Diagnostics Sales Reach $7.1B

Brian McCollum to Lead Orthofix Spine Global Business Unit

Lanx Raises $8.7M to Boost Sales of Fusion System, Introduce New Products

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.